Coffee & Cases Episode 6: The Impact of Restricting Out-of-Sequence Allocation in the U.S:

Recent Posts

• Verici Dx Named Olink® Certified Service Provider
• Verici Dx Announces Publication Describing Significant Cost Savings with Pre-Transplant Risk Assessment (PTRA) Test in Patients Preparing for Kidney Transplant
• Verici Dx Expands Scientific Advisory Board
• Verici Dx Appoints Paul Pagano, PhD, as Chief of Medical Affairs
• Verici Dx Receives New York State Approval, Establishing Nationwide Access to Tutivia™ Kidney Transplant Rejection Test